Cordis Global Medical Technology
ETL4642AU
Cordis Global Medical Technology ETL4642AU Strategy
The Fund follows a fundamental long-only active strategy. Cordis runs a high conviction actively managed specialised portfolio, limited to between 20-40 stocks selected from the medical technology sub-sector of listed global healthcare companies.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,660.30 | 22.50 | 0.26% |
| CAC 40 | 7,781.84 | 2.12 | 0.03% |
| DAX 40 | 24,094.68 | 161.45 | 0.67% |
| Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
| FTSE 100 | 8,766.94 | 50.49 | 0.58% |
| HKSE | 23,289.77 | 283.61 | -1.20% |
| NASDAQ | 19,175.87 | 74.93 | 0.39% |
| Nikkei 225 | 37,965.10 | 467.88 | -1.22% |
| NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
| S&P 500 | 5,912.17 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,434.70 | 24.90 | 0.30% |
| SSE Composite Index | 3,347.49 | 15.96 | -0.47% |